MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
CRMD — CorMedix Inc.
NasdaqCorMedix Inc.
$7.19
-0.23(-3.10%)
- O
- 7.45
- H
- 7.45
- L
- 7.17
- V
- 1.13M
⏱️ End-of-day dataAs of Oct 2, 2026
Chart
About CRMD
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
IndustryPHARMACEUTICAL PREPARATIONS
SectorNot available
IPO DateMay 13, 2010
Employees191
Stock ExchangeNasdaq
Ticker SymbolCRMD
Websitehttps://www.cormedix.com
Key Financial Statistics
| Market Cap | $611.86M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $6.13 - $13.02 |
| 52-Week Avg Volume | 1.88M |
| VWAP | $7.26 |
| Transactions | 13,037 |
| Total Recorded Bars | 4,122 days |